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Mitochondrial dysfunction has been associated with several human pathologies, including 
cancer, aging and neurodegenerative diseases. Thus, the availability of selective fluorescent 
probes for mitochondria could play an important role in the future for monitoring cellular 
function and disease progression. In this work, we have studied how the photophysical 
properties and subcellular accumulation of nonconventional coumarin-based COUPY 
fluorophores can be fine-tuned through replacement of the para-pyridinium moiety with 
several heterocycles. Among them, ortho,para-pyrimidinium substitution provided novel 
fluorophores with suitable photophysical properties for bioimaging applications, including 
emission in the far-red to NIR region, large Stokes’ shifts and high photostability. 
Furthermore, the compounds exhibited excellent cell membrane permeability in living cells 
and a higher selectivity for mitochondria compared with the parent COUPY fluorophores. 
Overall, these results provide useful insights for the development of novel mitochondria-
targeted fluorescent probes based on small organic molecules, since higher selectivity for this 
organelle can be achieved through the replacement of conventional N-alkylated pyridinium 






Fluorescence imaging in combination with organic fluorophores has become a powerful tool 
for understanding of biological events at a molecular level. In this context, the use of 
fluorescent probes with operability in the less energetic far-red and near-infrared (NIR) region 
of the electromagnetic spectrum offers several appealing features for in vivo imaging 
applications, such as increased tissue penetration depth and minimal autofluorescence 
interference from natively occurring biomolecules.1 For this reason, recent efforts have been 
devoted to the development of novel organic chromophores operating in the phototherapeutic 
window with optimal photophysical (e.g., long-wavelength absorption and emission, 
brightness, large Stokes’ shifts and photostability) and physicochemical (e.g., aqueous 
solubility, good cell permeability and target specificity) properties. Ideally, such fluorescent 
compounds should be based on chemically stable, low molecular weight scaffolds amenable 
to smart and simple structural modifications to fine-tune the abovementioned properties as 
well as to facilitate conjugation to targeting ligands.2 Besides biocompatibility, an ideal 
fluorophore should permit the interrogation of intracellular architectures and dynamics 
without disturbing and compromising the integrity of the cellular target.3 
Mitochondria are involved in many key cellular processes, including ATP synthesis, calcium 
signaling and redox homeostasis.4 Mitochondrial dysfunction has been associated with a wide 
range of human pathologies, such as cancer disease, aging and metabolic and 
neurodegenerative diseases.5 Thus, the availability of fluorescent dyes that can stain 
selectively mitochondria opens the door to monitoring cellular function and disease 
progression by studying mitochondrial morphology and mitophagy.6 Among fluorescent 
mitochondrial probes described to date, some of them intrinsically target this organelle such 
as some cyanine derivatives (e.g., IR-780 and MHI-148) and some rhodamines (Rhodamine 
123).7 Another approach to confer mitochondria selectivity consists of incorporating 
lipophilic positively charged moieties such as triphenylphosphonium or pyridinium groups, 
which exploit the negative potential across outer and inner mitochondria membrane.8 In this 
context, anticancer mitochondria-targeted fluorescent molecules are considered attractive 
theranostic agents.9 Similarly, mitochondria-targeted photocages based on organic 
chromophores provide a powerful method for releasing bioactive compounds within this 
organelle.10 
In our group, we have recently described a new class of coumarin-based chromophores in 
which the carbonyl group of the electron-withdrawing lactone in conventional coumarin 1 
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was replaced by cyano(4-pyridine)methylene moiety (e.g., compounds 2 and 3; see Scheme 1) 
with the aim of increasing the push-pull character of the -delocalized system.11 N-Alkylation 
of the pyridine heterocycle provides low molecular weight fluorophores, nicknamed 
COUPYs, with several attractive characteristics, including emission in the far-red/NIR region, 
large Stokes’ shifts and good brightness.11 Moreover, COUPY dyes (e.g., see compounds 4 
and 5 in Scheme 1 as representative examples) exhibited moderate to good aqueous solubility 
and excellent cell membrane permeability, and accumulate preferentially in two specific 
cellular compartments, mitochondria and nucleoli. After the discovery of this promising 
fluorescent platform, we have initiated a systematic study to unveil the principles governing 
the structure-photophysical property relationships (SPPR) of COUPY dyes, which are 
necessary to design new fluorescent probes according to need. Compared with conventional 
coumarins (e.g., 1), the molecular framework of COUPY scaffolds offers several advantages 
for carrying out a systematic SPPR study. Indeed, we have found that absorption and emission 
maxima can be red-shifted through the incorporation of strong electron-withdrawing groups 
like CF3 either at the 4-position or via N-alkylation of the pyridine heterocycle,
11 while 
photostability can be increased through replacement of the electron-donating N,N-dialkyl 
groups (e.g., NMe2 or NEt2) at position 7 with azetidine.
12 In addition, conjugatable versions 
of COUPY dyes can be easily obtained by incorporation of suitable functional groups (e.g., 
carboxylic acid, amino, azide or alkyne) via N-alkylation of the pyridine moiety. Such 
COUPY derivatives allowed us to label receptor-binding peptides on solid-phase by using 
efficient click chemistry methodologies,13 and to develop novel photosensitizers for 
photodynamic anticancer therapy via conjugation to cyclometalated Ir(III) complexes.14  
On the basis of all these precedents, in this work we focused on investigating how the 
modification of the pyridine moiety in COUPY chromophores could influence the 
photophysical properties and subcellular accumulation of the compounds. With this idea in 
mind, herein we describe the synthesis and characterization of four analogues (compounds 
10-13, Scheme 1) of our original COUPY dyes (4-5). Surprisingly, the replacement of para 
pyridine heterocycle by ortho pyridine (10) or ortho,ortho pyrimidine (11) had a negative 
effect on the spectroscopic properties of the compounds since both absorption and emission 
were blue-shifted. By contrast, the incorporation of ortho,para pyrimidine (12-13) led to 
highly photostable fluorophores with improved photophysical properties compared with the 
parent compounds, including emission in the far-red to NIR region and large Stokes’s shifts. 
Furthermore, high cell permeability was retained in both ortho,para-pyrimidine-containing 
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dyes and a higher selectivity for mitochondria of HeLa cells was achieved. Overall, these 
results provide new insights for the design and optimization of mitochondria-targeted 
fluorescent probes.  
 





RESULTS AND DISCUSSION 
Design, synthesis and characterization of COUPY dyes.  
COUPY dyes 10-13 were synthesized by following our previously described methodology for 
the parent dyes (4-5), which is based on the reaction of a thiocoumarin precursor with suitable 
heteroarylacetonitrile derivatives followed by N-methylation of the pyridine or pyrimidine 
moieties (Scheme 2). First, thiocoumarin 1815 was reacted with 2-(pyridin-2-yl)acetonitrile 
(14), 2-(pyrimidin-2-yl)acetonitrile (15) or 2-(pyrimidin-4-yl)acetonitrile (16) in the presence 
of NaH followed by AgNO3 treatment, which afforded COUPY scaffolds 6, 7 and 8, 
respectively, after purification by silica column chromatography with moderate to good yields 
(51-82%). Similarly, coumarin 9 was obtained by condensation of thiocoumarin 1911 with 16 
(yield 75%). All the compounds were fully characterized by reversed-phase HPLC (Figure 
S1), HR ESI-MS and 1H, 19F (only in the case of 9) and 13C NMR. 
 
Scheme 2. Synthesis of COUPY scaffolds (6-9) and of the corresponding N-methylated dyes (10-13). 
 
It is worth noting that 1H-1H NOESY experiments (Figures 1 and S2-S5) account for the 
existence of two species in equilibrium in solution because of the rotation around the 
exocyclic C=C bond, which reproduces the behavior previously found in the parent COUPY 
scaffolds (compounds 2 and 3, Scheme 1).11 As shown in Figure 1, chemical exchange cross-
peaks between the resonances of E and Z rotamers were observed in the 2D NOESY spectrum 
of coumarin 8. In the case of coumarins 6, 8 and 9, the two rotamers were present in a ∼60:40 
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ratio according to the integration of the 1H NMR spectrum, being the E rotamer the major 
species. This is in contrast with para-pyridine-containing coumarins 2 and 3 in which the E/Z 
ratio was ∼90:10. Surprinsingly, the Z rotamer was the major species in solution (95%) in the 
COUPY scaffold containing the ortho,ortho pyrimidine heterocycle (7), which was confirmed 
by the existence of a NOE cross-peak between the proton at position 3 of the coumarin moiety 
and the proton at the ortho position of the pyrimidine ring (Figure S3). It is worth noting that 
in all of the COUPY scaffolds the chemical shift of H3 appears at higher δ in the Z isomer 
(e.g., 8.18 ppm in 7 and 8.26 ppm in 8) than in the E isomer (e.g., 6.70 ppm in 7 and 6.75 ppm 
in 8).  
 
 
Figure 1. (A) Structures of the E and Z rotamers of coumarin 8. (B) Expansion of the 2D NOESY 
spectrum (tm = 500 ms, 25 °C) of 8 in DMSO-d6 showing NOE cross-peaks and exchange cross-





Next, we synthesized the corresponding N-methylated pyridinium (10) and pyrimidinium (11-
13) dyes by reaction with methyl trifluoromethanesulfonate in DCM at room temperature.11 
The four new coumarin derivatives were isolated after silica column chromatography as 
reddish-orange (10-11), purple (12) and dark blue (13) solids (yields 64-80 %), and their 
purity was assessed by reversed-phase HPLC (Figure S1). Characterization was carried out by 
HR ESI-MS and 1D and 2D NMR spectroscopy. As expected, methylation occurred at the 
less sterically-hindered nitrogen in the ortho,para-pyrimidine derivatives (12 and 13) 
according to NOESY NMR characterization, and in all cases the E rotamer was the major 
species in solution (Figures S6-S9). 
Photophysical characterization of COUPY fluorophores. 
Having at hand COUPY dyes 10-13, we investigated the effect of replacing the para-pyridine 
moiety in the parent fluorophores (4-5) by ortho-pyridine or by ortho,ortho- or ortho,para-
pyrimidine on the spectroscopic and photophysical properties of the compounds with the aim 
of establishing new SPPR. Although water or phosphate-buffered saline (PBS) are often used 
to evaluate the usefulness of a new fluorophore within a spectroscopy cuvette, the 
heterogeneity and complexity of the cellular environment cannot be accurately described by 
using a simple aqueous buffer.16 For this reason, we decided to register the UV-Vis absorption 
and emission spectra in four solvents of different polarity (PBS buffer pH 7.4, EtOH, ACN 
and DCM; Figures 2 and S10-S17) to get some insights on the photophysical behaviour of the 
compounds in polar and less-polar environments. As shown in Table 1, the photophysical 
properties of coumarins 10-13 were compared with those of the parent compounds 4-511 to 
facilitate the establishment of SPPR. 
All the new compounds exhibited an intense absorption band in the visible region of the 
electromagnetic spectrum, with absorption maxima ranging from 502 nm (10) to 600 nm (13) 
in aqueous solution (PBS pH 7.4), and from 543 nm (10) to 624 nm (13) in DCM. To our 
surprise, the absorption maximum of coumarin 10 was significantly blue-shifted with respect 
the reference compound 4 (e.g., compare abs = 515 and 543 nm for 10 and abs = 552 and 569 
nm for 4 in EtOH and DCM, respectively). Although not as pronounced as in the case of 10, a 
similar trend was found in ortho,ortho-pyrimidine-containing coumarin (11) since its 
absorption maximum was also blue-shifted (18-24 nm depending on the solvent) with respect 
4. By contrast, a slight red-shift was found in the absorption maximum of the ortho,para-
pyrimidine-containing coumarin 12 (12 nm in PBS and 6 nm in DCM). This red-shift was 
considerably larger in the 4-CF3 analogue (e.g., compare abs = 600 nm for 13 and abs = 568 
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nm for 5 in PBS). As previously found with the first generation of COUPY dyes,11,12 10-13 
showed negative solvatochromism since the absorption maxima was blue-shifted with 
increasing polarity of the solvent (e.g., compare the abs of 10-13 in DCM with the 
corresponding values in non-protic (ACN) and protic (EtOH) polar solvents). Moreover, the 
molar absorption coefficients of the two derivatives containing the ortho,para-pyrimidine 
moiety were similar even higher than to those of their respective parent dyes, especially in the 
4-CF3 analogue (e.g., compare  = 58 mM
-1cm-1 for 13 and  = 20 mM-1cm-1 for 5 in EtOH).  
 
The emission maxima of coumarins 10 and 11 were also blue-shifted both in polar and less-
polar solvents with respect coumarin 4 (e.g., em = 564 nm for 11 and em = 603 nm for 4 in 
EtOH), which reproduces the effect of replacing para-pyridine by ortho-pyridine or 
ortho,ortho-pyrimidine moieties on the compounds’ absorption maxima. By contrast, the 
emission maxima of COUPY dyes containing the ortho,para-pyrimidine moiety was red-
shifted with respect their parent compounds (11-24 nm in 12 and 6-19 nm in 13), especially in 
polar solvents. As a consequence, COUPY dyes 12 and 13 showed emission in the far-red to 
NIR region (Figures 2 and S10-S17), being the emission maximum in polar media particularly 
appealing in the case of the 4-CF3 fluorophore (em = 673 nm for 13 in PBS). Interestingly, 
coumarin 12 exhibited larger Stokes’ shifts than its parent dye 4 in all the solvents evaluated 
while the replacement of para-pyridine by ortho,para-pyrimidine in 5 led to slightly smaller 
values. Nevertheless, the Stokes’ shifts of 12 and 13 in polar solvents are sufficiently large 
(e.g., 71 and 73 nm in PBS, respectively) to avoid the light reabsorption problems typically 
found in bioimaging applications.1  
As shown in Table 1, compounds 10 and 11 exhibited very weak fluorescence in all the 
solvents investigated. By contrast, fluorescence quantum yields for coumarin 13 were much 
higher than those of the parent compound 5, especially in less-polar solvents (e.g., 0.41 and 
0.05 in DCM, respectively). This tendency was reversed in the case of the 4-CH3 analogue 
since the ΦF for 12 was smaller compared with 4 (e.g., 0.11 and 0.70 in DCM, respectively). 
Both ortho,para-pyrimidine-containing compounds exhibited moderate fluorescence quantum 







Table 1. Photophysical data of the coumarin derivatives 4-5 and 10-13 in different solvents. 
 











4 CH, CH, N 
PBS 545 34000 604 59 0.12 
EtOH 552 59000 603 51 0.45 
ACN 548 75000 609 61 0.18 
DCM 569 67000 607 38 0.70 
10 N, CH, CH 
PBS 502 25000 583 81 0.01 
EtOH 515 31000 592 77 0.02 
ACN 505 26000 589 84 0.02 
DCM 543 36000 594 51 0.20 
11 N, N, CH 
PBS 525 37000 561 36 0.01 
EtOH 528 59000 564 36 0.11 
ACN 526 23000 575 49 0.02 
DCM 551 45000 565 14 0.02 
12 N, CH, N 
PBS 557 56000 628 71 0.01 
EtOH 558 58000 615 57 0.13 
ACN 557 50000 621 64 0.10 
DCM 575 73000 618 43 0.11 
5 CH, CH, N 
PBS 568 14000 660 92 0.02 
EtOH 568 20000 648 80 0.05 
ACN 569 47000 668 99 0.02 
DCM 600 34000 657 57 0.05 
13 N, CH, N 
PBS 600 35000 673 73 0.02 
EtOH 598 58000 667 69 0.08 
ACN 597 42000 674 77 0.10 
DCM 624 60000 663 39 0.41 
a Wavelength of the absorption maximum; b Molar absorption coefficient at max; c Wavelength of the 
emission maximum upon excitation at a wavelength 20 nm below max; d Stokes’ shift; e Fluorescence 
quantum yields (ΦF) were measured by comparative method using Cresyl Violet in ethanol (F;Ref = 
0.54) as reference for compounds 4-5 and 12-13. Fluorescein dissolved in aqueous sodium hydroxide 





Figure 2. Comparison of the normalized absorption (solid lines) and fluorescence (dotted lines) 
spectra of COUPY dyes (compounds 4-5 and 12-13) in EtOH.  
 
Finally, the photostability of the most promising coumarins (12 and 13) was investigated in 
PBS buffer (pH 7.4) under green LED irradiation (Figures 3 and S18). As shown in Figure 3, 
the replacement of pyridine in coumarin 4 with ortho,para-pyrimidine had a positive effect on 
the photostability of the resulting fluorophore (12). By contrast, coumarin 13 was found less 
photostable than its parent compound 5 and coumarin 12, which indicates that replacement of 
the CH3 group at the 4-position with CF3 in ortho,para-pyrimidine-containing COUPY dyes 
does not lead to an improvement of the overall photostability of the compounds. Nevertheless, 
it is worth noting that the two new pyrimidine-containing COUPY dyes were found 
photostable up to light fluences larger than 1000 J/cm2 (12) and 200 J/cm2 (13), which are 
more than 50- and 10-fold, respectively, higher than those typically used in imaging 

























Figure 3. Fluorescence bleaching of COUPY dyes (4-5, 12-13) in PBS buffer pH 7.4 (5 M) 
irradiated with green light (505 nm, 100 mW/cm2). 
 
In summary, all these observations allowed us to stablish some structure-photophysical 
property relationships. First, replacement of para-pyridine in COUPY dyes with ortho-
pyridine or ortho,ortho-pyrimidine moieties had a negative effect on the spectroscopic 
properties of the fluorophores since both absorption and emission maxima were blue-shifted. 
Moreover, compounds 10 and 11 were found weakly fluorescent and their extinction 
coefficients were smaller than those of the parent coumarin 4. By contrast, the photophysical 
properties of COUPY dyes were clearly improved when para-pyridine was replaced with 
ortho,para-pyrimidine. On the one hand, both absorption and emission maxima were red-
shifted with respect the parent compounds, especially in polar protic solvents. Indeed, the 
incorporation of the second nitrogen atom in the pyridine moiety in 5 caused a red-shift of the 
absorption (32 nm) and emission (12 nm) bands in PBS pH 7.4 in the resulting coumarin 13 
when compared with the parent compound. Very interestingly, the emission of 13 was 
extended beyond 750 nm (Figure 2), which would facilitate in vivo imaging. Although the 
incorporation of the ortho,para-pyrimidine moiety caused a slight decrease in the fluorescent 
quantum yields of the compounds (e.g., compare ΦF of 4 and 12), the combination of this 
heterocycle with the CF3 group at position 4 seems to compensate this phenomenon, leading 
to moderate ΦF values in protic and non-protic polar solvents (0.08-0.13) in the case of 




















Fluorescence imaging of COUPY dyes in living cells 
Taking into account the large photostability and the photophysical properties of the two 
ortho,para-pyrimidine-containing COUPY dyes (12 and 13), we decided to evaluate their 
usefulness as fluorescent probes in a more realistic situation (e.g., in living cells). As 
previously stated, the heterogeneous environment of an organic fluorophore within a cell or 
within a specific cellular organelle might be considerably different than the homogeneity of a 
solution in a spectroscopy cuvette. In fact, the presence of biomolecules such as proteins and 
lipids or the interaction with the components of cellular membranes might provide the 
fluorescent probe with an environment less hydrophilic than expected, thereby modifying key 
parameters for bioimaging applications such as brightness. 
The cellular uptake of 12 and 13 was first investigated in living HeLa cells (2 M, 30 min 
incubation) by using confocal microscopy and compared with that of the para-pyridine-
containing coumarins (compounds 4 and 5, respectively). Irradiation was carried out with a 
yellow light laser (λex = 561 nm) in the case of 4-CH3 coumarins (4 and 12), while the higher 
red-shift absorption of the 4-CF3 compounds (5 and 13) allowed the use of a red one (λex = 
633 nm). As shown in Figure 4, in all cases the fluorescence signal was clearly observed 
inside the cell, which confirms that the excellent cellular uptake of the parent COUPY dyes 
was retained after replacement of pyridine with pyrimidine. In addition, it is worth noting that 
no cell toxicity was observed during these studies. The overall pattern of staining (but not the 
relative fluorescence intensity between organelles; see below for a discussion) of pyrimidine-
containing coumarins (12 and 13) was similar to that found with the parent fluorophores (4 
and 5), suggesting accumulation in mitochondria, nucleoli and, to a lesser extent, in 
intracellular vesicles, mostly lysosomes. Co-localization experiments with two specific 
markers for labeling mitochondria (MitoTracker Green FM, MTG), and lysosomes 




Figure 4. Cellular uptake of COUPY fluorophores 4 (A), 5 (B), 12 (C) and 13 (D). Single confocal 
planes of HeLa cells incubated with the compounds (2 M, 30 min, 37ºC). White arrows point out 
mitochondria, white arrowheads nucleoli and yellow arrowheads vesicles staining. Scale bar: 20 m. 
All images are at the same scale as A and colour coded using the Fire lookup table from Fiji (intensity 
calibration bar is showed in B). 
 
As shown in Figure 5, the distribution of the fluorescence emission of the compounds was 
similar to that of Mitotracker Green FM, which confirmed accumulation into the 
mitochondria. Pearson’s and Manders’ (M1 and M2) coefficients were used to measure the 
degree of co-localization.11-12,18 On the one hand, Pearson’s coefficients of 0.86 (12) and 0.87 
(13) confirmed a clear correlation between the coumarins’ signals and MTG (Pearson’s 
coefficients range from −1 to +1, being +1 the indicator of a perfect match). Such coefficients 
were higher than those obtained for the parent COUPY dyes (0.65 for 4 and 0.73 for 5), 
indicating a better correlation between pyrimidine-containing coumarins and MTG. On the 
other hand, the Manders’ coefficients (which range from 0 to 1 and determine the intensities 
of one channel co-localizing with the other) also confirmed that 12 and 13 were mainly placed 
in the mitochondria. The degree of co-localization of 12 over MTG (M1 coefficient) was 
0.40, whereas that of MTG over 12 (M2 coefficient) was 0.73. These values indicate that 
there is more MTG signal co-localizing with 12 than 12 that co-localizing with MTG. The 
localization of the coumarin probe in other organelles such as nucleoli and intracellular 
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vesicles accounts for the differences in both Manders coefficients. It is worth noting that 
smaller values for M1 (0.28) and M2 (0.68) were obtained in the case of the parent coumarin 
4, which indicates that the signal from the fluorophore that co-localizes with MTG is higher in 
the case of pyrimidine-containing coumarin (12) than in the pyridine analogue (4), thereby 
suggesting a higher preference for mitochondria. Although not as pronounced, a similar trend 
was found for coumarins 13 (M1 = 0.19 and M2 = 0.86) and 5 (M1 = 0.18 and M2 = 0.76).  
 
 
Figure 5. Co-localization studies with COUPY dyes 12 (top) and 13 (bottom) and Mitotracker Green 
FM. Single confocal plane of HeLa cells incubated with 12 or 13 (2 M, red) and Mitotracker Green 
FM (0.1 M, green). A), D) Overlay of the two staining. B), E) coumarin 12 and 13 signal, 
respectively. C), F) Mitotracker Green FM signal. Scale bar: 10 m. All images are at the same scale 
as A. 
 
As previously found with the parent fluorophores,12 co-localization experiments with LTG 
(Figure 6) confirmed that most of fluorescence observed in intracellular vesicles along the 
cytoplasm was associated with lysosome accumulation (Pearson’s coefficients being equal to 
0.52 (12) and 0.49 (13) on average). The smaller Mander’s coefficients for the co-localization 
of the compounds over LTG (M1 = 0.02 for 12 and 13) and of LTG over the coumarins (M2 = 
0.45 for 12 and 0.62 for 13) in the co-localization experiment with LTG compared with MTG 
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might be explained by a reduced affinity of COUPY dyes for lysosome and/or by lower 
abundance of this organelle in cells compared with mitochondria. 
Very interestingly, the nucleoli inside the nuclei was much less intensely stained in 
compounds 12 and 13 than in the parent coumarins: compare in Figure 4 panels C (12) and D 
(13) with panels A (4) and B (5), respectively. As shown in Figure 7, measurement of the 
mean fluorescence intensity both in mitochondria and nucleoli confirmed this observation. 
Indeed, the mean intensity for mitochondria and nucleoli was quite similar in the parent 
coumarins 4 and 5 whereas the mean intensity for nucleoli staining was considerably reduced 
in the case of the pyrimidine analogues 12 and 13. These results are in line with the higher 
M1 coefficients measured in co-localization experiments with MTG and indicate that 
replacement of para-pyridine by ortho,para-pyrimidine in COUPY dyes caused an increase in 
the selectivity of the compounds towards mitochondria. 
 
 
Figure 6. Co-localization studies with COUPY dyes and Lysotracker Green FM. Single confocal 
plane of HeLa cells incubated with coumarins 12 and 13 (2 M, red) and Lysotracker Green FM (0.2 
M, green). A), D) Overlay of the two staining. B), E) coumarins 12 and 13 signal, respectively. C), 
F) Lysotracker Green FM staining. White arrowheads point out COUPY dyes vesicles colocalizing 





Figure 7. Graphic of COUPY dyes 4, 5, 12 and 13 mean intensity (Arbitrary Units) at the 
mitochondria and nucleoli.  
 
Finally, the photostability of coumarins 12 and 13 was evaluated in a more realistic situation 
and compared with that of the parent compounds (4 and 5, respectively). For this purpose, 
living HeLa cells were incubated at 37 ºC with the compounds and irradiated continuously 
with the laser beam of the confocal microscope (λex= 561 nm at 4.32 W for 4 and 12, and 
λex= 633 nm at 10.2 W for 5 and 13), and images were acquired with an interval time of 0.42 
sec for 4.5 min. As shown in Figures S19 and S20, the overall fluorescence signal was 
significantly decreased in all the cases, In good agreement with photobleaching studies 
(Figure 3), the ortho,para-containing coumarin 12 was found slightly more photostable than 
its parent compound (4), while this trend was found opposite in the case of the 4-CF3 
containing compounds. Nevertheless, it is worth noting that the laser power used in the 
photobleaching experiments was much higher than the one used during conventional 
observation (0.3 W and 1.7 W with 561 nm and 633 nm lasers, respectively) which 
confirms a good photostability and applicability of these molecules for imaging living cells by 





In summary, in this manuscript we have investigated how the photophysical properties and 
subcellular accumulation of coumarin-based COUPY fluorophores can be fine-tuned through 
replacement of the para-pyridine moiety with different heterocycles (ortho-pyridine and 
ortho,ortho- or ortho,para-pyrimidine), with the aim of establishing new structure-
photophysical property relationships. COUPY dyes 10-13 were easily obtained from cheap, 
commercially available compounds in three linear synthetic steps, the reaction of 
thiocoumarins with suitable heteroarylacetonitrile derivatives followed by N-methylation of 
the pyridine or pyrimidine moieties being the key steps. Very interestingly, the photophysical 
properties of the new fluorophores were strongly influenced by these modifications. On the 
one hand, the replacement of para-pyridine moiety with ortho-pyridine (10) or ortho,ortho-
pyrimidine (11) had a negative effect on the spectroscopic properties of the dyes since both 
absorption and emission were blue-shifted, leading to weakly fluorescent compounds. On the 
other hand, the absorption and emission maxima of ortho,para-pyrimidine-containing 
fluorophores (12-13) were red-shifted with respect the parent compounds, particularly in polar 
solvents. Besides emission in the far-red to NIR region, the newly synthesized fluorophores 
exhibited other appropriate characteristics for bioimaging applications such as large Stokes’ 
shifts and high photostability. Furthermore, coumarins 12 and 13 retained the excellent cell 
permeability of COUPY dyes but exhibited a higher preference for mitochondria. Overall, 
these results provide useful indications for the development of novel mitochondria-targeted 
fluorescent probes based on small organic compounds since we have demonstrated that the 
selectivity for this organelle can be improved through the replacement of N-alkylated 





Materials and Methods 
Unless otherwise stated, common chemicals and solvents (HPLC grade or reagent grade 
quality) were purchased from commercial sources and used without further purification. 
Aluminium plates coated with a 0.2 mm thick layer of silica gel 60 F254 were used for thin-
layer chromatography analyses (TLC), whereas flash column chromatography purification 
was carried out using silica gel 60 (230-400 mesh). Reversed-phase high-performance liquid 
chromatography (HPLC) analyses were carried out on a Jupiter Proteo C18 column (250x4.6 
mm, 90 Å 4 m, flow rate: 1 mL/min) using linear gradients of 0.1% formic acid in H2O (A) 
and 0.1% formic acid in ACN (B). NMR spectra were recorded at 25 oC in a 400 MHz 
spectrometer using the deuterated solvent as an internal deuterium lock. The residual protic 
signal of chloroform or DMSO was used as a reference in 1H and 13C NMR spectra recorded 
in CDCl3 or DMSO-d6, respectively. Chemical shifts are reported in part per million (ppm) in 
the  scale, coupling constants in Hz and multiplicity as follows: s (singlet), d (doublet), t 
(triplet), q (quartet), qt (quintuplet), m (multiplet), dd (doublet of doublets), dq (doublet of 
quartets), br (broad signal), etc. The proton signals of the E and Z rotamers were identified by 
simple inspection of the 1H spectrum and the rotamer ratio was calculated by peak integration. 
2D-NOESY spectra were acquired in DMSO-d6 with a mixing time of 500 ms, either at 298 k 
or 350 K. Electrospray ionization mass spectra (ESI-MS) were recorded on an instrument 
equipped with single quadrupole detector coupled to an HPLC, and high-resolution (HR) ESI-
MS on a LC/MS-TOF instrument.  
Synthesis of pyrimidin-acetonitrile derivatives  
2-(Pyrimidin-2-yl)acetonitrile (15) 
A solution of KCN (0.63 g, 9.70 mmol) in DMSO (5 mL) was slowly added to a solution of 
2-(chloromethyl)pyrimidine (0.5 g, 3.89 mmol) in DMSO (4 mL). The reaction mixture was 
stirred overnight at 35 oC with a hot plate magnetic stirrer. After addition of 50 mL of K2CO3 
(10%), the aqueous phase was extracted with diethyl ether (10 x 30 mL). The combined 
organic fractions were dried over anhydrous Na2SO4, filtered and evaporated under reduced 
pressure. The crude product was purified by column chromatography (silica gel, 0-15% ethyl 
acetate in DCM) to give 84 mg of a colourless oil (yield 19%). TLC: Rf (ethyl acetate/DCM 
1:1) 0.44. 1H NMR (400 MHz, CDCl3,  (ppm)): 8.74 (2H, d, J = 5.1 Hz), 7.29 (1H, t, J = 5.1 
Hz), 4.11 (s, 2H). 13C{1H} NMR (101 MHz, CDCl3,  (ppm)): 161.4, 158.0, 120.3, 116.1, 




A modified method was followed to synthesize compound 16.19  
(E)-N,N-Dimethyl-2-(pyrimidin-4-yl)ethen-1-amine (17) 
4-Methylpyrimidine (10 g, 106 mmol) and 1,1-dimethoxy-N,N-dimethylmethanamine (38 g, 
319 mmol) were dissolved in 50 mL of anhydrous DMF. The solution was heated at 140ºC 
with a hot plate magnetic stirrer for 24 h. The crude product was evaporated under reduced 
pressure to provide 17 as a brown oil, which was used without further purification. TLC: Rf 
(DCM/MeOH 9:1) 0.50. 1H NMR (400 MHz, CDCl3,  (ppm)): 8.73 (1H, s), 8.21 (1H, d, J = 
5.6 Hz), 7.76 (1H, d, J = 13 Hz), 6.71 (1H, dd, J = 5.6, 1.6 Hz), 4.99 (1H, d, J = 13 Hz), 2.95 
(6H, s).  
2-(Pyrimidin-4-yl)acetonitrile (16) 
A solution of hydroxylamine-O-sulfonic acid (7.31 g, 57.5 mmol) in Milli-Q water (100 mL) 
was added to the crude product 17, and the reaction mixture was heated at 50 ºC with a hot 
plate magnetic stirrer for 45 min. Then, the mixture was cooled at 0 ºC and saturated NaHCO3 
was added until basic pH, and the aqueous phase extracted with ethyl acetate (6 x 200 mL). 
The combined organic phases were dried over anhydrous Na2SO4, filtered and evaporated 
under reduced pressure. The brown oil was purified by column chromatography (silica gel, 0-
25% ethyl acetate in DCM) to give 1.46 g of a yellow solid (yield 11%). TLC: Rf (ethyl 
acetate/DCM 1:1) 0.34. 1H NMR (400 MHz, CDCl3,  (ppm)): 9.20 (1H, s), 8.80 (1H, d, J = 
5.2 Hz), 7.51 (1H, d, J = 5.2 Hz), 3.94 (2H, s). 13C{1H} NMR (101 MHz, CDCl3,  (ppm)): 
159.3, 159.2, 158.3, 119.7, 115.5, 26.5. LRMS (ESI-TOF) (m/z): [M+H]+ Calcd for C6H6N3, 
120.06; found, 119.90. 
Synthesis of COUPY scaffolds (6-9) 
2-(Cyano(2-pyridine)methylene)-7-(N,N-diethylamino)-4-methyl-coumarin (6) 
7-(N,N-Diethylamino)-4-methyl-2-thiocoumarin 18 (0.25 g, 1.01 mmol), 2-(pyridin-2-
yl)acetonitrile 14 (0.24 g, 2.02 mmol) and NaH (60% dispersion in mineral oil, 0.36 g, 9 
mmol) were dissolved in anhydrous acetonitrile (15 mL) and the mixture was stirred for 2 h 
under an argon atmosphere at room temperature and protected from light. Then, AgNO3 (0.34 
g, 2.02 mmol) was added and the resulting mixture was stirred for 2 h under Ar at room 
temperature. The crude product was evaporated under reduced pressure and purified by 
column chromatography (silica gel, 0-25% ethyl acetate in DCM) to give 240 mg of an 
orange solid (yield 72%). TLC: Rf (ethyl acetate/DCM 1:1) 0.90. 
1H NMR (400 MHz, 
DMSO-d6,  (ppm)): (E + Z rotamers) 8.56 (1H, m), 8.13 (0.6H, dt, J = 8.2, 0.8 Hz), 7.82 
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(1.4H, m), 7.46 (1.4H, m), 7.18 (1H, m), 6.70 (1H, dd, J = 9.0, 2.4 Hz), 6.65 (1.2H, m), 6.42 
(0.4H, d, J = 2.4 Hz), 3.46 (4H, q, J = 7.2 Hz,), 2.35 (1.8H, d, J = 0.8 Hz), 2.32 (1.2H, d, J = 
0.8 Hz), 1.14 (6H, m). 13C{1H} NMR (101 MHz, DMSO-d6,  (ppm)): (E + Z rotamers) 
163.2, 161.8, 154.0, 153.8, 152.7, 152.0, 150.6, 150.5, 149.0, 148.8, 144.6, 144.0, 137.1, 
136.8, 126.0, 125.9, 121.8, 121.2, 120.7, 120.2, 119.6, 119.3, 110.8, 110.4, 109.8, 109.2, 
109.1, 96.7, 96.1, 85.3, 81.0, 44.0, 43.8, 18.5, 18.0, 12.4. HRMS (ESI-TOF) (m/z): [M+H]+ 
Calcd for C21H22N3O, 332.1763; found, 332.1759. Analytical HPLC (30−100% B in 30 min, 
formic acid additive): Rt = 15.2 min. 
2-(Cyano(2-pyrimidine)methylene)-7-(N,N-diethylamino)-4-methyl-coumarin (7) 
7-(N,N-Diethylamino)-4-methyl-2-thiocoumarin 18 (0.25 g, 1.01 mmol), 2-(pyrimidin-2-
yl)acetonitrile 15 (0.24 g, 2.02 mmol) and NaH (60% dispersion in mineral oil, 0.36 g, 9 
mmol) were dissolved in anhydrous acetonitrile (15 mL) and the mixture was stirred for 2 h 
under an argon atmosphere at room temperature and protected from light. Then, AgNO3 (0.34 
g, 2.02 mmol) was added and the resulting mixture was stirred for 2 h under Ar at room 
temperature. The crude product was evaporated under reduced pressure and purified by 
column chromatography (silica gel, 0-10% ethyl acetate in DCM) to give 171 mg of an 
orange solid (yield 51%). TLC: Rf (ethyl acetate/DCM 1:1) 0.63. 
1H NMR (400 MHz, 
DMSO-d6,  (ppm)): (major rotamer) 8.74 (2H, d, J = 4.8 Hz), 8.18 (1H, s), 7.53 (1H. d, J = 
9.0 Hz), 7.17 (1H, t, J = 4.8 Hz), 6.76 (1H, dd, J = 9.0, 2.4 Hz), 6.46 (1H, d, J = 2.4 Hz), 3.47 
(4H, q, J = 7.2 Hz), 2.39 (3H, s), 1.15 (6H, t, J = 6.9 Hz). 13C{1H} NMR (101 MHz, DMSO-
d6,  (ppm)): (major rotamer) 166.6, 162.9, 157.0, 154.1, 150.9, 146.6, 126.3, 118.4, 116.6, 
110.5, 109.9, 109.7, 96.0, 82.5, 44.1, 18.7, 12.4. HRMS (ESI-TOF) (m/z): [M+H]+ Calcd for 
C20H21N4O, 333.1715; found, 333.1710. Analytical HPLC (30−100% B in 30 min, formic 
acid additive): Rt = 21.2 min.  
2-(Cyano(4-pyrimidine)methylene)-7-(N,N-diethylamino)-4-methyl-coumarin (8) 
7-(N,N-Diethylamino)-4-methyl-2-thiocoumarin 18 (0.25 g, 1.01 mmol), 2-(pyrimidin-4-
yl)acetonitrile 16 (0.24 g, 2.02 mmol) and NaH (60% dispersion in mineral oil, 0.36 g, 9 
mmol) were dissolved in anhydrous acetonitrile (15 mL) and the mixture was stirred for 2 h 
under an argon atmosphere at room temperature and protected from light. Then, AgNO3 (0.34 
g, 2.02 mmol) was added and the resulting mixture was stirred for 2 h under Ar at room 
temperature. The crude product was evaporated under reduced pressure and purified by 
column chromatography (silica gel, 0-25% ethyl acetate in DCM) to give 275 mg of an 
orange solid (yield 82%). TLC: Rf (ethyl acetate/DCM 1:1) 0.50. 
1H NMR (400 MHz, 
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DMSO-d6,  (ppm)): (E + Z rotamers) 9.04 (1H, m), 8.69 (0.6H, d, J = 5.6 Hz), 8.62 (0.4H, d, 
J = 5.6 Hz), 8.26 (0.4H, d, J = 0.8 Hz), 8.18 (0.6H, dd, J = 5.6, 1.6 Hz), 7.59 (0.4H, d, J = 9.2 
Hz), 7.56 (0.6H, d, J = 8.8 Hz), 7.42 (0.4H, dd, J = 5.6, 1.6 Hz), 6.81 (1.6H, m), 6.75 (0.6H, 
d, J = 0.8 Hz), 6.51 (0.4H, d, J = 2.8 Hz), 3.49 (4H, m), 2.43 (1.2H, d, J = 1.2 Hz),2.42 (1.7H, 
d, J = 1.2 Hz), 1.16 (6H, t, J = 7.0 Hz). 13C{1H} NMR (101 MHz, DMSO-d6,  (ppm)): (E + Z 
rotamers) 165.5, 165.2, 160.3, 159.1, 158.1, 157.6, 156.9, 156.7, 154.2, 151.2, 151.0, 148.5, 
147.6, 126.5, 126.4, 118.6, 118.4, 117.5, 116.9, 116.7, 110.6, 110.4, 110.3, 110.2, 109.2, 96.6, 
95.8, 82.8, 78.5, 44.1, 43.9 18.8, 18.2, 12.4, 12.3. HRMS (ESI-TOF) (m/z): [M+H]+ Calcd for 
C20H21N4O, 333.1715; found, 333.1709. Analytical HPLC (30−100% B in 30 min, formic 
acid additive): Rt = 17.5 min.  
2-(Cyano(4-pyrimidine)methylene)-7-(N,N-dimethylamino)-4-trifluoromethyl-coumarin 
(9) 
7-(N,N-Dimethylamino)-4-trifluoromethyl-2-thiocoumarin 19 (0.25 g, 0.92 mmol), 2-
(pyrimidin -4-yl)acetonitrile 16 (0.22 g, 1.83 mmol) and NaH (60% dispersion in mineral oil, 
0.33 g, 8.25 mmol) were dissolved in anhydrous acetonitrile (15 mL) and the mixture was 
stirred for 2 h under an argon atmosphere at room temperature and protected from light. Then, 
AgNO3 (0.31 g, 1.83 mmol) was added and the resulting mixture was stirred for 2 h under Ar 
at room temperature. The crude product was evaporated under reduced pressure and purified 
by column chromatography (silica gel, 0-10% ethyl acetate in DCM) to give 248 mg of a red 
solid (yield 75%). TLC: Rf (ethyl acetate/DCM 1:1) 0.30 and 0.64. 
1H NMR (400 MHz, 
DMSO-d6,  (ppm)): (E + Z rotamers) 9.17 (0.55H, d, J = 1.2 Hz), 9.15 (0.45H, d, J = 1.2 
Hz), 8.83 (0.55H, d, J = 5.6 Hz), 8.78 (0.45H, d, J = 5.6 Hz), 8.74 (0.45H, s), 8.28 (0.55H, dd, 
J = 5.6, 1.6 Hz), 7.56 (0.45H, dd, J = 5.6, 1.6 Hz), 7.44 (1H, m), 7.03 (0.55H, s), 7.00 (0.55H, 
d, J = 2.8 Hz), 6.87 (1H, m), 6.64 (0.45H, d, J = 2.4 Hz), 3.13 (3.3H, s), 3.11 (2.7H, s). 
13C{1H} NMR (101 MHz, DMSO-d6,  (ppm)): (E + Z rotamers) 163.3, 162.6, 158.7, 158.3, 
157.9, 157.7, 157.6, 154.6, 154.5, 153.7, 153.6, 125.3, 118.8, 117.9, 117.4, 116.8, 111.0, 
110.9, 110.8, 110.7, 110.7, 110.5, 110.4, 110.4, 103.5, 102.5, 98.1, 97.4, 89.7, 89.5, 85.2, 
39.7. 19F NMR (376 MHz, DMSO-d6) δ (ppm): (E + Z rotamers) -63.0 (1.35F, s), -63. (1.65F, 
s). HRMS (ESI-TOF) (m/z): [M+H]+ Calcd for C18H14F3N4O, 359.1114; found, 359.1112. 
Analytical HPLC (30−100% B in 30 min, formic acid additive): Rt = 22.8 min.  
Synthesis of COUPY fluorophores (10-13) 
2-(Cyano(1-methyl(2-pyridin-1-ium))methylene)-7-(N,N-diethylamino)-4-methyl-
coumarin triflate (10) 
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Methyl trifluoromethanesulfonate (47.5 μL, 0.42 mmol) was added to a solution of 2-
(cyano(2-pyridine)methylene)-7-(N,N-diethylamino)-4-methyl-coumarin 6 (70 mg, 0.21 
mmol) in DCM (30 mL) under an argon atmosphere. The mixture was stirred for 4 h at room 
temperature and protected from light. The reaction mixture was evaporated under reduced 
pressure and purified by column chromatography (silica gel, 0-3% MeOH in DCM) to give 77 
mg of a red solid (yield 74%). TLC: Rf (DCM/MeOH 9:1) 0.35. 
1H NMR (400 MHz, 77 ºC, 
DMSO-d6,  (ppm)): 9.02 (1H, d, J = 6.4 Hz), 8.53 (1H, td, J = 7.6, 1.2 Hz), 8.26 (1H, d, J = 
8.0 Hz), 8.00 (1H, td, J = 7.6, 1.2 Hz), 7.59 (1H, d, J = 9.2 Hz), 6.83 (1H, dd, J = 9.2, 2.4 Hz), 
6.62 (1H, br s), 6.51 (1H, br s), 4.28 (3H, s), 3.46 (4H, q, J = 7.2 Hz), 2.43 (3H, s), 1.15 (6H, 
t, J = 7.2 Hz). 13C{1H} NMR (101 MHz, 77 ºC, DMSO-d6,  (ppm)): 165.6, 153.9, 151.2, 
149.3, 147.8, 147.1, 144.6, 130.5, 126.2, 125.3, 120.5 (q, J = 323 Hz, Tf), 116.5, 110.3, 109.4, 
108.0, 96.2, 71.0, 46.0, 43.7, 17.6, 12.0. 19F NMR (376 MHz, DMSO-d6) δ (ppm): -77.8 (3F, 
s). HRMS (ESI-TOF) (m/z): [M]+ Calcd for C22H24N3O, 346.1914; found, 346.1911. 
Analytical HPLC (30−100% B in 30 min, formic acid additive): Rt = 5.5 min. 
2-(Cyano(1-methyl(2-pyrimidin-1-ium))methylene)-7-(N,N-diethylamino)-4-methyl-
coumarin triflate (11) 
Methyl trifluoromethanesulfonate (47.5 μL, 0.42 mmol) was added to a solution of 2-
(cyano(2-pyrimidine)methylene)-7-(N,N-diethylamino)-4-methyl-coumarin 7 (70 mg, 0.21 
mmol) in DCM (30 mL) under an argon atmosphere. The mixture was stirred for 4 h at room 
temperature and protected from light. Then, an additional amount of methyl 
trifluoromethanesulfonate (47.5 μL, 0.42 mmol) was added to the reaction mixture and was 
stirred during 2 h. The reaction mixture was evaporated under reduced pressure and purified 
by column chromatography (silica gel, 0-4% MeOH in DCM) to give 66 mg of an orange 
solid (yield 64%). TLC: Rf (DCM/MeOH 9:1) 0.31. 
1H NMR (400 MHz, DMSO-d6,  
(ppm)): 9.28 (1H, dd, J = 4.2, 2.0 Hz), 9.16 (1H, dd, J = 6.6, 1.8 Hz), 7.91 (1H, dd, J = 6.4, 
5.6 Hz, 1H), 7.70 (1H, d, J = 9.2 Hz), 7.06 (1H, s), 6.94 (1H, dd, J = 9.2, 2.8 Hz), 6.70 (1H, d, 
J = 2.8 Hz), 4.14 (3H, s), 3.50 (4H, q, J = 7.2 Hz), 2.49 (3H, s), 1.15 (6H, t, J = 7.2 Hz). 
13C{1H} NMR (101 MHz, DMSO-d6,  (ppm)): 162.9 157.6, 154.7, 154.6, 152.5, 151.8, 
127.1, 120.7 (q, J = 323 Hz, Tf), 118.7, 116.8, 111.6, 110.4, 109.2, 96.0, 73.4, 46.5, 44.2, 
18.5, 12.3. 19F NMR (376 MHz, DMSO-d6) δ (ppm): -77.8 (3F, s). HRMS (ESI-TOF) (m/z): 
[M]+ Calcd for C21H23N4O, 347.1866; found, 347.1865. Analytical HPLC (30−100% B in 30 




coumarin triflate (12) 
Methyl trifluoromethanesulfonate (47.5 μL, 0.42 mmol) was added to a solution of 2-
(cyano(4-pyrimidine)methylene)-7-(N,N-diethylamino)-4-methyl-coumarin 8 (70 mg, 0.21 
mmol) in DCM (30 mL) under an argon atmosphere. The mixture was stirred for 4 h at room 
temperature and protected from light. The reaction mixture was evaporated under reduced 
pressure and purified by column chromatography (silica gel, 0-2% MeOH in DCM) to give 83 
mg of a violet solid (yield 80%). TLC: Rf (DCM/MeOH 9:1) 0.28. 
1H NMR (400 MHz, 77 
ºC, DMSO-d6,  (ppm)): 9.11 (1H, m), 8.53 (1H, dd, J = 7.6, 2.0 Hz), 8.00 (1H, d, J = 7.6 
Hz), 7.84 (1H, d, J = 9.2 Hz), 7.60 (1H, br s), 7.09 (1H, dd, J = 9.2, 2.4 Hz), 6.89 (1H, d, J = 
2.4 Hz), 4.02 (3H, s), 3.60 (4H, q, J = 7.2 Hz), 2.63 (3H, s), 1.23 (6H, t, J = 7.2 Hz). 13C{1H} 
NMR (101 MHz, DMSO-d6,  (ppm)): 167.3, 163.4, 155.6, 155.5, 152.7, 152.2, 147.5, 127.5, 
120.7 (q, J = 323 Hz, Tf), 117.4, 114.8, 113.1, 111.5, 110.7, 95.9, 44.4, 42.5, 18.9, 12.4. 19F 
NMR (376 MHz, DMSO-d6) δ (ppm): -77.8 (3F, s). HRMS (ESI-TOF) (m/z): [M]
+ Calcd for 
C21H23N4O 347.1866; found, 347.1866. Analytical HPLC (30−100% B in 30 min, formic acid 
additive): Rt = 5.4 min. 
2-(Cyano(1-methyl(4-pyrimidin-1-ium))methylene)-7-(N,N-dimethylamino)-4-
trifluoromethyl-coumarin triflate (13) 
Methyl trifluoromethanesulfonate (47.3 μL, 0.40 mmol) was added to a solution of 2-
(cyano(4-pyrimidine)methylene)-7-(N,N-dimethylamino)-4-trifluoromethyl-coumarin 9 (70 
mg, 0.20 mmol) in DCM (30 mL) under an argon atmosphere. The mixture was stirred for 4 h 
at room temperature and protected from light. The reaction mixture was evaporated under 
reduced pressure and purified by column chromatography (silica gel, 0-2% MeOH in DCM) 
to give 75 mg of a blue solid (yield 72%). TLC: Rf (DCM/MeOH 9:1) 0.48. 
1H NMR (400 
MHz, 77 ºC, DMSO-d6,  (ppm)): 9.40 (1H, s), 8.81 (1H, dd, J = 7.4, 1.8 Hz), 8.21 (1H, br s), 
7.65 (1H, dq, J = 9.2, 2.0 Hz), 7.13 (1H, dd, J = 9.2, 2.6 Hz), 7.01 (1H, br s), 4.13 (3H, s), 
3.22 (6H, s). 13C{1H} NMR (101 MHz, 77 ºC DMSO-d6,  (ppm)): 166.8, 163.2, 158.8, 
156.0, 155.4, 154.5, 153.1, 152.4, 136.7 (q, J = 32 Hz), 125.4, 124.9, 121.5 (q, J = 277 Hz), 
120.5 (q, J = 323 Hz), 116.6, 115.6, 113.3, 109.7, 108.4, 107.7, 101.5, 97.7, 97.2, 43.0, 40.0. 
19F NMR (376 MHz, DMSO-d6) δ (ppm): -63.1 (3F, s), -77.8 (3F, s). HRMS (ESI-TOF) 
(m/z): [M]+ Calcd for C19H16F3N4O 373.1271; found, 373.1274. Analytical HPLC (30−100% 




Photophysical characterization of the compounds. 
Absorption spectra were recorded in a Jasco V-730 spectrophotometer at room temperature. 
Molar absorption coefficients () were determined by direct application of the Beer-Lambert 
law, using solutions of the compounds in each solvent with concentrations ranging from 10−6 
to 10−5 M. Emission spectra were registered in a Photon Technology International (PTI) 
fluorimeter. Fluorescence quantum yields (ΦF) were measured by comparative method using 
Cresyl Violet in ethanol (F;Ref = 0.54) as reference for compounds 4-5 and 12-13. 
Fluorescein dissolved in aqueous sodium hydroxide (0.1 M; ΦF;Ref =0.92) was used as 
reference in the case of compounds 10-11.17 Then, optically-matched solutions of the 
compounds and CV were excited and the fluorescence spectra was recorded. The absorbance 
of sample and reference solutions was set below 0.1 at the excitation wavelength and F were 









𝑥 ф𝐹;𝑟𝑒𝑓  (1) 
where AreaSample and AreaRef are the integrated fluorescence for the sample and the reference 
and ƞSample and ƞRef are the refractive index of sample and reference solutions respectively. 
The uncertainty in the experimental value of F has been estimated to be approximately 10%. 
Photostability studies were performed by monitoring fluorescence bleaching of a 5 M PBS 
solution (pH 7.4) of the compounds at 37 ºC irradiated with a high power 505 nm LED (100 
mW/cm2). Fluorescence intensity values were recorded at t = 0 (F0) and after different 
irradiation times (F). 
Cell Culture and Treatments. HeLa cells were maintained in DMEM (Dullbecco Modified 
Eagle Medium) containing high glucose (4.5 g/L) and supplemented with 10% fetal calf 
serum (FCS) and 50 U/mL penicillin-streptomycin. For cellular uptake experiments and 
posterior observation under the microscope, cells were seeded on glass-bottom dishes (P35G-
1.5-14-C, Mattek). Twenty-four hours after cell seeding, cells were incubated for 30 min at 37 
°C with COUPY dyes (4, 5, 12 or 13, 2 μM) in supplemented DMEM. Then cells were 
washed three times with DPBS (Dulbecco’s phosphate-buffered saline, pH 7.0-7.3) to remove 
the excess of the fluorophores and kept in low glucose DMEM without phenol red for 
fluorescence imaging. 
For colocalization experiments with Mitotracker Green FM, HeLa cells were treated with 
COUPY dyes (2 μM) and MitoTracker Green FM (0.1 μM) for 30 min at 37 °C in 
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nonsupplemented DMEM. After removal of the medium and washing three times with DPBS, 
cells were kept in low glucose DMEM without phenol red for fluorescence imaging. 
For colocalization experiments with Lysotracker Green FM and Hoechst 33342, HeLa cells 
were treated with COUPY dyes (2 μM) and LysoTracker Green FM (0.2 μM) for 30 min at 37 
°C in nonsupplemented DMEM. After removal of the medium and washing three times with 
DPBS, cells were incubated for 10 min at 37 °C with Hoechst 33342 (1 μg/mL) in 
supplemented DMEM. Finally, cells were washed and kept in low glucose DMEM without 
phenol red for fluorescence imaging. 
Fluorescence Imaging. All microscopy observations were performed using a Zeiss LSM 880 
confocal microscope equipped with a 405 nm laser diode, an argon-ion laser, a 561 nm laser, 
and a 633 nm laser. The microscope was also equipped with a Heating Insert P S (Pecon) and 
a 5% CO2 providing system. Cells were observed at 37ºC using a 63× 1.2 glycerol immersion 
objective. Coumarins 4 and 12 were excited using the 561 nm laser and detected from 570 to 
670 nm. Coumarins 5 and 13 were excited using the 633 nm laser and detected from 643 to 
758 nm. In colocalization studies, Mitotracker Green FM and Lysotracker Green were 
observed using the 488 nm laser line of the argon-ion laser, whereas the 405 nm laser diode 
was used for observing Hoechst 33342. 
Bleaching experiments were performed at 37 ºC by continuous image acquisition with an 
interval time of 0.42 sec for 4.5 min. Coumarins 4 and 12 were bleached using the 561 nm 
laser at 4.32 W and coumarins 5 and 13 were bleached with the 633 nm laser at 10.2 W. 
Image processing and analysis was performed using Fiji.20  
Intensity measurement: the nuclei and coumarin channels were processed by median 
filtering (radius = 2), Gaussian filtering (sigma = 2) and background subtraction (rolling ball 
radius = 300). Mean intensity in the nucleoli was measured in the maximum intensity 
projection of the processed coumarin image after manually draw ROIs around each nucleoli. 
Intensity measurement in mitochondria needed of further processing. First, the nuclei were 
segmented using Intermodes algorithm,21 and the resulting binary image was processed by 
filling holes and opening operations. Then the binary image of the nuclei was subtracted to 
the processed coumarin image to get rid of any nuclear signal. After the subtraction, the 
coumarin staining channel was projected by the maxim intensity and the mitochondria were 
segmented using the Phansalkar algorithm (radius = 5).22 The binary image of the 
mitochondria was used as a mask to obtain the coumarin signal in the mitochondria and then 
measure its mean intensity. 
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Bleaching analysis: Images were first processed by median filtering (radius = 1) and 
background subtraction (rolling ball radius = 50). Then a ROI was manually drawn around 
each cell and in the background to measure the mean intensity along time. Intensity 
normalization was performed using the following equation (2):  
𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 =
𝐶𝑒𝑙𝑙(𝑡) − 𝐵𝑎𝑐𝑘𝑔 (𝑡)
𝐶𝑒𝑙𝑙(0) − 𝐵𝑎𝑐𝑘𝑔 (0)
 (2) 
were Cell(t) is the mean intensity in a cell at a t time, Cell(0) is the mean intensity in that cell 
at the beginning of the experiment, Backg(t) is the mean intensity in the background at a t 
time and Backg(0) is the mean intensity in the background at the beginning of the experiment. 
After intensity normalization, the time at which the intensity dropped to half of the initial one 
(t50) was obtained. Differences between the different t50 of coumarin 4 and 12 were tested 
with a T-Student. 
Co-localizations coefficients. The mitotracker or lysotracker and coumarin channels were 
processed by median filtering (radius = 1), Gaussian filtering (sigma = 1) and background 
subtraction (rolling ball radius = 300). Colocalization coefficients were measured using the 
JaCoP plugin17 on the different stacks of images (n = 4) with each stack containing 3−5 cells. 
The threshold for the coumarin channel was set to include the signal in the mitochondria, 
nucleoli and vesicles. The threshold for the mitotracker or lysotracker channels was set to 




Copies of HPLC traces and UV−vis absorption and fluorescence emission spectra of the 
compounds; additional fluorescence imaging studies; 1D NMR (1H, 13C, and 19F), MS, and 
selected 2D NMR spectra.  
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